Pfizer Stock Future Price Prediction

PFE
 Stock
  

USD 44.08  0.49  1.10%   

Pfizer Inc stock price prediction is an act of determining the future value of Pfizer shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pfizer's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Pfizer and does not consider all of the tangible or intangible factors available from Pfizer's fundamental data. We analyze noise-free headlines and recent hype associated with Pfizer Inc, which may create opportunities for some arbitrage if properly timed.
Please check Pfizer Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pfizer based on different types of headlines from major news networks to social media. The Pfizer stock price prediction module provides an analysis of price elasticity to changes in media outlook on Pfizer over a specific investment horizon.Using Pfizer hype-based prediction, you can estimate the value of Pfizer Inc from the perspective of Pfizer response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Pfizer using Pfizer's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Pfizer using crowd psychology based on the activity and movement of Pfizer's stock price.

Pfizer Implied Volatility

    
  34.17  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Pfizer. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Pfizer to buy its stock at a price that has no basis in reality. In that case, they are not buying Pfizer because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Pfizer after-hype prediction price

    
  $ 44.01  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Pfizer contract

Based on the Rule 16, the options market is currently suggesting that Pfizer Inc will have an average daily up or down price movement of about 2.14% per day over the life of the 2022-09-30 option contract. With Pfizer trading at $44.08, that is roughly $0.94. If you think that the market is fully incorporating Pfizer's daily price movement you should consider acquiring Pfizer Inc options at the current volatility level of 34.17%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Pfizer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Pfizer in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
39.6752.5954.01
Details
Naive
Forecast
LowNext ValueHigh
41.7943.2144.64
Details
12 Analysts
Consensus
LowTarget PriceHigh
41.0058.9275.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
43.2044.9146.62
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pfizer. Your research has to be compared to or analyzed against Pfizer's peers to derive any actionable benefits. When done correctly, Pfizer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Pfizer Inc.

Pfizer After-Hype Price Prediction Density Analysis

As far as predicting the price of Pfizer at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pfizer or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pfizer, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Pfizer Estimiated After-Hype Price Volatility

In the context of predicting Pfizer's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pfizer's historical news coverage. Pfizer's after-hype downside and upside margins for the prediction period are 42.59 and 45.43, respectively. We have considered Pfizer's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 44.08
44.01
After-hype Price
45.43
Upside
Pfizer is very steady asset. Analysis and calculation of next after-hype price of Pfizer Inc is based on 3 months time horizon.

Pfizer Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pfizer, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.23  1.42   0.07    0.14  9 Events / Month0 Events / MonthIn about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
44.0844.010.16 
458.06  

Pfizer Hype Timeline

On the 25th of September Pfizer Inc is traded for 44.08. The entity has historical hype elasticity of -0.07 and average elasticity to hype of competition of -0.14. Pfizer is forecasted to decline in value after the next headline with the price expected to drop to 44.01. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next newsis expected to be -0.16% whereas the daily expected return is at this time at -0.23%. The volatility of related hype on Pfizer is about 225.4% with expected price after next announcement by competition of 43.94. About 69.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 11.36. The company last dividend was issued on the 28th of July 2022. Pfizer Inc had 3:1 split on the 17th of November 2020. Considering the 90-day investment horizon the next forecasted press release will be in about 9 days.
Please check Pfizer Basic Forecasting Models to cross-verify your projections.

Pfizer Related Hype Analysis

Having access to credible news sources related to Pfizer's direct competition is more important than ever and may enhance your ability to predict Pfizer's future price movements. Getting to know how Pfizer rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pfizer may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SGMLSigma Lithium Corp(0.63) 5 per month 4.06  0.15  7.99 (6.19)  18.46 

Pfizer Additional Predictive Modules

Most predictive techniques to examine Pfizer price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pfizer using various technical indicators. When you analyze Pfizer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Pfizer Predictive Indicators

The successful prediction of Pfizer stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pfizer Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pfizer based on analysis of Pfizer hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pfizer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pfizer's related companies.

Story Coverage note for Pfizer

The number of cover stories for Pfizer depends on current market conditions and Pfizer's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pfizer is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pfizer's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Pfizer Short Properties

Pfizer's future price predictability will typically decrease when Pfizer's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pfizer Inc often depends not only on the future outlook of the potential Pfizer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pfizer's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out1.20%
Trailing Annual Dividend Rate1.52
Short Percent Of Float1.20%
Float Shares5.61B
Shares Short Prior Month76.98M
Average Daily Volume Last 10 Day18.04M
Average Daily Volume In Three Month17.71M
Date Short Interest15th of July 2022
Trailing Annual Dividend Yield3.41%
Please check Pfizer Basic Forecasting Models to cross-verify your projections. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.